Home
About Us
Issues
Authors
Reviewers
Users
Subscription
Our Other Journals
Site map
Aims and Scope
Salient Features
Editorial Board
Editorial Statements
Editorial-PeerReview Process
Publication Ethics & Malpractice
Ijars Performance
Journal Policy
Contact Us
Current Issue
Forthcoming
Article Archive
Access Statistics
Simple Search
Advanced Search
Submit an Article
Instructions
Assistance
Publication Fee
Paid Services
Apply As Reviewer
Acknowledgment
Register Here Edit Register
Register For Article Submission
Login Here Logout
Login For Article Submission
Annual
Buy One Issue
Payment Options
How to Order
JCDR
IJNMR
NJLM

 

Welcome : Guest

Users Online :

 

 

 

 

 

 

 

 

Original article / research

2021
Year :2021 Month : January-February Volume : 10 Issue : 1 Page : RO13 - RO16

COVID-19: Chest CT Imaging Patterns in Assessment of Disease Progression and Severity

Published: January 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/46853.2591
Correspondence Address :
Sachin Thammegowda, Sudha Kiran Das, Raghu Ramachandra, Shashikiran Ramachandraiah, Shashank Honnegowda,
Dr. Sachin Thammegowda,
Department of Radiology, Hassan Institute of Medical Sciences, Hassan-573201, Karnataka, India.
E-mail: tsachin67@gmail.com
Introduction: Introduction: Chest Computed Tomography (CT) plays an important role in the diagnosis and management of Corona Virus Disease (COVID-19) infection. A better understanding of the chest CT imaging findings in COVID-19 disease may help in accurate diagnosis and staging of the disease. The temporal changes in the chest CT imaging findings follows a specific pattern which helps in identification of disease progression or recovery from the illness.

Aim: To evaluate the chest CT imaging findings of COVID-19 patients during the course of disease.

Materials and Methods: This was a retrospective observational study in which 110 hospitalised patients with COVID-19 disease were evaluated for chest CT imaging findings and severity of the infection. Chest CT findings with respect to duration of symptoms onset were divided into early phase disease (<5 days of symptom onset), intermediate phase (5-12 days) and late phase disease (>12 days of symptom onset). Based on visual assessment, CT severity score was given depending on the percentage of each lobe involved in bilateral lung parenchyma. Descriptive statistics were expressed using percentage, range, means and Standard Deviation (mean±SD).

Results: A total of 110 COVID-19 positive patients (79 males and 31 females) with mean age of 48.33±9.18 years (range between 22-84 years) were included in the study. CT chest was performed during the different time periods of hospital stay ranging from 2 to 16 days. Early phase disease constituted 53 (48.18%) patients, 21 (19.09%) patients in the intermediate phase and 36 (32.72%) patients were in the late phase. Nineteen (17.27%) patients in the early phase disease (<5 days) had a normal scan. Out of 91 chest CT positive patients, 13 patients (14.28%) were asymptomatic and 78 patients were symptomatic (85.71%). Among the CT positive patients, early phase disease constituted 34 (37.36%) patients, 21 (23.07%) patients were in the intermediate phase and 36 (39.56%) patients in the late phase disease. Early phase disease was predominantly characterised by Ground Glass Opacities (GGOs) which were seen in 27 patients (79.41%), gradual conversion of these GGOs into consolidations during the intermediate phase. Consolidations with fibrotic bands were predominant imaging patterns during the late phase disease seen in 21 patients (58.33%). Mean CT severity score during the early, intermediate and late phase diseases were 4.14±2.12, 14.71±4.80 and 11.08±4.68, respectively. Along with few existing signs described in COVID-19 disease, two signs during the late phase disease were observed such as target sign in 5 patients (13.88%) and centipede sign in 13 patients (36.11%). Splenomegaly was an additional extrapulmonary finding seen in 27 patients (24.5%) which has not been described previously.

Conclusion: Specific imaging patterns during the course of COVID-19 illness provide an information regarding the stage of the illness and disease severity. Ideal timing of chest CT is found to be during the intermediate phase of disease (5-12 days of symptom onset), since most of the lesions evolve in this period and provide accurate disease severity which in turn helps in treatment planning.
 
[ FULL TEXT ]   |   [ ]
 

Article Utilities

  • Readers Comments
  • Article in PDF
  • Citation Manager
  • Article Statistics
  • Link to PUBMED
  • Print this Article
  • Send to a Friend

Quick Links

REVIEWER
ACCESS STATISTICS
Home  |  About Us  |  Online First  |  Current Issue  |  Simple Search  |  Advance Search  |  Register  |  Login  |  Contact  |  Privacy Policy  |  Terms of Use
Author Support  |  Submit Manuscript  |  IJARS Pre-Publishing  |  Reviewer  |  Articles Archive  |  Access Statistics
©INTERNATIONAL JOURNAL OF ANATOMY RADIOLOGY & SURGERY (IJARS), ISSN : 2277-8543.
EDITORIAL OFFICE : 1/9, Roop Nagar, Delhi 11000. Phone : 01123848553

* This Journal is owned and run by medical professionals *